These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 24073630)

  • 1. Cytotoxic properties of sunitinib and sorafenib on human corneal epithelial cells.
    Bayyoud T; Hofmann J; Spitzer M; Bartz-Schmidt KU; Yoeruek E
    Curr Eye Res; 2014 Feb; 39(2):149-54. PubMed ID: 24073630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety profile of bevacizumab on cultured human corneal cells.
    Yoeruek E; Spitzer MS; Tatar O; Aisenbrey S; Bartz-Schmidt KU; Szurman P
    Cornea; 2007 Sep; 26(8):977-82. PubMed ID: 17721300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of toxicity of sorafenib and sunitinib for human keratinocytes with inhibition of signal transduction and activator of transcription 3 (STAT3).
    Yamamoto K; Mizumoto A; Nishimura K; Uda A; Mukai A; Yamashita K; Kume M; Makimoto H; Bito T; Nishigori C; Nakagawa T; Hirano T; Hirai M
    PLoS One; 2014; 9(7):e102110. PubMed ID: 25013907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinome and Transcriptome Profiling Reveal Broad and Distinct Activities of Erlotinib, Sunitinib, and Sorafenib in the Mouse Heart and Suggest Cardiotoxicity From Combined Signal Transducer and Activator of Transcription and Epidermal Growth Factor Receptor Inhibition.
    Stuhlmiller TJ; Zawistowski JS; Chen X; Sciaky N; Angus SP; Hicks ST; Parry TL; Huang W; Beak JY; Willis MS; Johnson GL; Jensen BC
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29051215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of sorafenib and sunitinib in the induction of expressions of NKG2D ligands in nasopharyngeal carcinoma with high expression of ABCG2.
    Huang Y; Wang Y; Li Y; Guo K; He Y
    J Cancer Res Clin Oncol; 2011 May; 137(5):829-37. PubMed ID: 20809412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) gene dosage on plasma pharmacokinetics and brain accumulation of dasatinib, sorafenib, and sunitinib.
    Tang SC; de Vries N; Sparidans RW; Wagenaar E; Beijnen JH; Schinkel AH
    J Pharmacol Exp Ther; 2013 Sep; 346(3):486-94. PubMed ID: 23843632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of the multikinase inhibitors sorafenib and sunitinib with solute carriers and ATP-binding cassette transporters.
    Hu S; Chen Z; Franke R; Orwick S; Zhao M; Rudek MA; Sparreboom A; Baker SD
    Clin Cancer Res; 2009 Oct; 15(19):6062-9. PubMed ID: 19773380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-transduced MDCKII cells to study human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) interplay in drug transport across the blood-brain barrier.
    Poller B; Wagenaar E; Tang SC; Schinkel AH
    Mol Pharm; 2011 Apr; 8(2):571-82. PubMed ID: 21309545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential sensitivity of prostate tumor derived endothelial cells to sorafenib and sunitinib.
    Fiorio Pla A; Brossa A; Bernardini M; Genova T; Grolez G; Villers A; Leroy X; Prevarskaya N; Gkika D; Bussolati B
    BMC Cancer; 2014 Dec; 14():939. PubMed ID: 25494980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Multikinase inhibitors as a new approach in neovascular age-related macular degeneration (AMD) treatment: in vitro safety evaluations of axitinib, pazopanib and sorafenib for intraocular use].
    Thiele S; Liegl RG; König S; Siedlecki J; Langer J; Eibl K; Haritoglou C; Kampik A; Kernt M
    Klin Monbl Augenheilkd; 2013 Mar; 230(3):247-54. PubMed ID: 23508753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitization of ABCG2-overexpressing cells to conventional chemotherapeutic agent by sunitinib was associated with inhibiting the function of ABCG2.
    Dai CL; Liang YJ; Wang YS; Tiwari AK; Yan YY; Wang F; Chen ZS; Tong XZ; Fu LW
    Cancer Lett; 2009 Jun; 279(1):74-83. PubMed ID: 19232821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elacridar enhances the cytotoxic effects of sunitinib and prevents multidrug resistance in renal carcinoma cells.
    Sato H; Siddig S; Uzu M; Suzuki S; Nomura Y; Kashiba T; Gushimiyagi K; Sekine Y; Uehara T; Arano Y; Yamaura K; Ueno K
    Eur J Pharmacol; 2015 Jan; 746():258-66. PubMed ID: 25455500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the multitargeted tyrosine kinase inhibitors imatinib, dasatinib, sunitinib, and sorafenib on mitochondrial function in isolated rat heart mitochondria and H9c2 cells.
    Will Y; Dykens JA; Nadanaciva S; Hirakawa B; Jamieson J; Marroquin LD; Hynes J; Patyna S; Jessen BA
    Toxicol Sci; 2008 Nov; 106(1):153-61. PubMed ID: 18664550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statins potentiate cytostatic/cytotoxic activity of sorafenib but not sunitinib against tumor cell lines in vitro.
    Bil J; Zapala L; Nowis D; Jakobisiak M; Golab J
    Cancer Lett; 2010 Feb; 288(1):57-67. PubMed ID: 19632769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential biomarkers for the therapeutic efficacy of sorafenib, sunitinib and everolimus.
    Nakai Y; Miyake M; Morizawa Y; Hori S; Tatsumi Y; Anai S; Onishi S; Tanaka N; Fujimoto K
    Oncol Rep; 2017 Jan; 37(1):227-234. PubMed ID: 27840968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxic effects of recombinant tissue plasminogen activator on cultured human corneal endothelial cells.
    Yoeruek E; Spitzer MS; Tatar O; Biedermann T; Grisanti S; Lüke M; Bartz-Schmidt KU; Szurman P
    Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1392-7. PubMed ID: 18385055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous adverse effects in patients treated with the multitargeted kinase inhibitors sorafenib and sunitinib.
    Lee WJ; Lee JL; Chang SE; Lee MW; Kang YK; Choi JH; Moon KC; Koh JK
    Br J Dermatol; 2009 Nov; 161(5):1045-51. PubMed ID: 19558553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Both sunitinib and sorafenib are effective treatments for pheochromocytoma in a xenograft model.
    Denorme M; Yon L; Roux C; Gonzalez BJ; Baudin E; Anouar Y; Dubessy C
    Cancer Lett; 2014 Oct; 352(2):236-44. PubMed ID: 25016061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is sunitinib a Narrow Therapeutic Index Drug? - A systematic review and in vitro toxicology-analysis of Sunitinib vs. Imatinib in cells from different tissues.
    Haas B; Weber-Lassalle K; Frötschl R; Eckstein N
    Regul Toxicol Pharmacol; 2016 Jun; 77():25-34. PubMed ID: 26924275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytostatic and cytotoxic effects of 5-fluorouracil on human corneal epithelial cells and keratocytes.
    Midena E; Lazzarini D; Catania AG; Moretto E; Fregona I; Parrozzani R
    Cornea; 2013 Mar; 32(3):338-44. PubMed ID: 22968358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.